Drugs / TD_PUR INJ
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01402713 Comparator | Aug 2011 → Nov 2013 | bacterial infectious disease | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TD_PUR INJ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01402713 ↗ |